April 2021
-
04.22.2021 Finance Pfizer Announces 2021 Shareholder Meeting Results -
04.09.2021 Covid-19 Vaccines Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use of Their COVID-19 Vaccine to Adolescents
March 2021
-
03.03.2021 Covid-19 Vaccines Pfizer-BioNTech’s COVID-19 Vaccine Arrives in Rwanda
February 2021
-
02.19.2021 Covid-19 Vaccines President Biden Visits Pfizer’s Kalamazoo Manufacturing Facility -
02.17.2021 Covid-19 Research In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer- BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations -
02.08.2021 Covid-19 Research Vaccines Pfizer and BioNTech Publish Data from In Vitro Studies in Nature Medicine Demonstrating COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants -
02.01.2021 Covid-19 Research Vaccines Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature
January 2021
-
01.29.2021 Covid-19 Research Pfizer and BioNTech Publish Data on COVID-19 Vaccine-Induced Antibodies’ Ability to Neutralize SARS-CoV-2 U.K. Strain Pseudovirus in Cell Culture in Science -
01.26.2021 Responsibility Statement on ATMI Ranking -
01.20.2021 Covid-19 Vaccines Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture -
01.15.2021 Covid-19 Statement on European Upscaling as well as Impact on Deliveries -
01.15.2021 Leadership Statement by Pfizer Chairman and CEO Albert Bourla